MCRM Announces Affiliation with Regulatory Affairs Associates Firms, Brings Regulatory Services to New Plymouth Township Facility
At the groundbreaking for the Michigan Center for Regenerative Medicine (MCRM), a magnet facility for adult stem-cell research, manufacturing and commercialization, it was announced that Regulatory Affairs Associates is joining the facility as a partner when the facility construction is completed. - October 27, 2010
Regulatory Affairs Associates Announces Innovative FDA Medical Device Consulting Provided Within Federal Contract
Regulatory Affairs Associates (RAA) announced today it has been awarded the project as FDA regulatory consultants to Visca Corporation for the development of a break-through biomarker medical device. RAA participated in writing the successful contract bid to the Federal Government. The device will... - April 02, 2010
Regulatory Affairs Associates Provides U. of Michigan Pediatric Devices with FDA Support
Regulatory Affairs Associates (RAA) announced today that the company will provide FDA consulting services to the University of Michigan Pediatric Device Consortium (M-PED). The consortium is funded by a 2-year, $2 million dollar grant from the Food and Drug Administration and will promote... - March 18, 2010
Regulatory Affairs Associates Announces Partnership with Ohio State University to Manufacture New Drug
Regulatory Affairs Associates announced today that a contract was signed with Ohio State University to manufacture clinical supplies for a break-through drug to prevent oral cancer. The drug will be tested at multiple clinical sites in the United States during 2010. The topical gel formulation... - January 20, 2010